Nuria Fernández Piñeiro, Oskar Ayerdi Aguirrebengoa, Eva Orviz García, Cristina González Pérez, Mar Vera García, Teresa Puerta López, Carmen Rodríguez Martín, Clara Lejarraga Cañas, Jorge Perez García, Begoña Baza Caraciolo, Monserrat González Polo, Florentina Alcudia Pérez, Marta Ruiz Fernández, Natividad Jerez Zamora, Diego Morales Irala, Beatriz López Centeno, Daniele Alioto, José Manuel Martínez Sesmero, Vicente Estrada Pérez, María Teresa Benítez Gimenez, Jorge Del Romero Guerrero
{"title":"马德里社区的暴露前预防计划：两年的经验。","authors":"Nuria Fernández Piñeiro, Oskar Ayerdi Aguirrebengoa, Eva Orviz García, Cristina González Pérez, Mar Vera García, Teresa Puerta López, Carmen Rodríguez Martín, Clara Lejarraga Cañas, Jorge Perez García, Begoña Baza Caraciolo, Monserrat González Polo, Florentina Alcudia Pérez, Marta Ruiz Fernández, Natividad Jerez Zamora, Diego Morales Irala, Beatriz López Centeno, Daniele Alioto, José Manuel Martínez Sesmero, Vicente Estrada Pérez, María Teresa Benítez Gimenez, Jorge Del Romero Guerrero","doi":"10.1016/j.eimce.2024.06.001","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Pre-exposure prophylaxis (PrEP) against the human immunodeficiency virus (HIV) is an effective and safe preventive measure. However, it has not reached all target users who could benefit from it. The study aimed to understand the sociodemographic, clinical and behavioral baseline characteristics of PrEP users. As a secondary objective, the use of concomitant medication and drug consumption were described.</p><p><strong>Methodology: </strong>Observational, retrospective and descriptive study of the sociodemographic, clinical and behavioral characteristics of the users who were included in the PrEP program of the Community of Madrid during the first two years of experience.</p><p><strong>Results: </strong>Two thousand two hundred fifty-six PrEP users were included, 99.0% men, with a mean age of 36.9 years (SD 8.68). 33.1% presented a sexually transmitted infection (STI) on the first visit, highlighting chlamydiasis and rectal gonococci. 70.4% reported using drugs associated with sex, and 42.4% participated in chemsex sessions in the last 3 months. A high percentage of users with concomitant medication was observed (37.6%), highlighting drugs related to mental health and alopecia.</p><p><strong>Conclusions: </strong>A multidisciplinary approach is required to cover all the needs of PrEP users, including mental health evaluation measures and addiction treatment with the clinical approach.</p>","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pre-exposure prophylaxis program in the Community of Madrid: Two years of experience.\",\"authors\":\"Nuria Fernández Piñeiro, Oskar Ayerdi Aguirrebengoa, Eva Orviz García, Cristina González Pérez, Mar Vera García, Teresa Puerta López, Carmen Rodríguez Martín, Clara Lejarraga Cañas, Jorge Perez García, Begoña Baza Caraciolo, Monserrat González Polo, Florentina Alcudia Pérez, Marta Ruiz Fernández, Natividad Jerez Zamora, Diego Morales Irala, Beatriz López Centeno, Daniele Alioto, José Manuel Martínez Sesmero, Vicente Estrada Pérez, María Teresa Benítez Gimenez, Jorge Del Romero Guerrero\",\"doi\":\"10.1016/j.eimce.2024.06.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Pre-exposure prophylaxis (PrEP) against the human immunodeficiency virus (HIV) is an effective and safe preventive measure. However, it has not reached all target users who could benefit from it. The study aimed to understand the sociodemographic, clinical and behavioral baseline characteristics of PrEP users. As a secondary objective, the use of concomitant medication and drug consumption were described.</p><p><strong>Methodology: </strong>Observational, retrospective and descriptive study of the sociodemographic, clinical and behavioral characteristics of the users who were included in the PrEP program of the Community of Madrid during the first two years of experience.</p><p><strong>Results: </strong>Two thousand two hundred fifty-six PrEP users were included, 99.0% men, with a mean age of 36.9 years (SD 8.68). 33.1% presented a sexually transmitted infection (STI) on the first visit, highlighting chlamydiasis and rectal gonococci. 70.4% reported using drugs associated with sex, and 42.4% participated in chemsex sessions in the last 3 months. A high percentage of users with concomitant medication was observed (37.6%), highlighting drugs related to mental health and alopecia.</p><p><strong>Conclusions: </strong>A multidisciplinary approach is required to cover all the needs of PrEP users, including mental health evaluation measures and addiction treatment with the clinical approach.</p>\",\"PeriodicalId\":72916,\"journal\":{\"name\":\"Enfermedades infecciosas y microbiologia clinica (English ed.)\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Enfermedades infecciosas y microbiologia clinica (English ed.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.eimce.2024.06.001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enfermedades infecciosas y microbiologia clinica (English ed.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.eimce.2024.06.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Pre-exposure prophylaxis program in the Community of Madrid: Two years of experience.
Introduction: Pre-exposure prophylaxis (PrEP) against the human immunodeficiency virus (HIV) is an effective and safe preventive measure. However, it has not reached all target users who could benefit from it. The study aimed to understand the sociodemographic, clinical and behavioral baseline characteristics of PrEP users. As a secondary objective, the use of concomitant medication and drug consumption were described.
Methodology: Observational, retrospective and descriptive study of the sociodemographic, clinical and behavioral characteristics of the users who were included in the PrEP program of the Community of Madrid during the first two years of experience.
Results: Two thousand two hundred fifty-six PrEP users were included, 99.0% men, with a mean age of 36.9 years (SD 8.68). 33.1% presented a sexually transmitted infection (STI) on the first visit, highlighting chlamydiasis and rectal gonococci. 70.4% reported using drugs associated with sex, and 42.4% participated in chemsex sessions in the last 3 months. A high percentage of users with concomitant medication was observed (37.6%), highlighting drugs related to mental health and alopecia.
Conclusions: A multidisciplinary approach is required to cover all the needs of PrEP users, including mental health evaluation measures and addiction treatment with the clinical approach.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
